A pilot study of clinical cell therapies in Alzheimer’s disease
Tài liệu tham khảo
Duncan, 2017, Alzheimer's disease, dementia, and stem cell therapy, Stem Cell Res Ther, 8, 111, 10.1186/s13287-017-0567-5
Brookmeyer, 2018, Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States, Alzheimers Dement, 14, 121, 10.1016/j.jalz.2017.10.009
Hane, 2017, Recent progress in Alzheimer's disease research, part 3: diagnosis and treatment, J Alzheimers Dis, 57, 645, 10.3233/JAD-160907
Stamegna, 2018, Grafts of olfactory stem cells restore breathing and motor functions after rat spinal cord injury, J Neurotrauma, 35, 1765, 10.1089/neu.2017.5383
Bonnet, 2020, Immediate or delayed transplantation of a vein conduit filled with nasal olfactory stem cells improves locomotion and axogenesis in rats after a peroneal nerve loss of substance, Int J Mol Sci, 21, 10.3390/ijms21082670
Wang, 2020, Olfactory ensheathing cells in chronic ischemic stroke: a phase 2, double- blind, randomized, controlled trial, J Neurorestoratol, 8, 182, 10.26599/JNR.2020.9040019
Guo, 2019, Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review, J Neurorestoratol, 7, 82, 10.26599/JNR.2019.9040009
Huang, 2020, Standards of clinical-grade olfactory ensheathing cell culture and quality control (2020 China Version), J Neurorestoratol, 8, 217, 10.26599/JNR.2020.9040023
Holbrook, 2011, Immunohistochemical characterization of human olfactory tissue, Laryngoscope, 121, 1687, 10.1002/lary.21856
Lu, 2017, Differentiation of human olfactory mucosa mesenchymal stem cells into photoreceptor cells in vitro, Int J Ophthalmol, 10, 1504
Zhou, 2012, Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up, Cell Transplant, 21, S39, 10.3727/096368912X633752
Saberi, 2008, Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes, Neurosci Lett, 443, 46, 10.1016/j.neulet.2008.07.041
Saberi, 2011, Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases, J Neurosurg Spine, 15, 515, 10.3171/2011.6.SPINE10917
van Horne, 2018, Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-upstudy of safety, feasibility, and clinical outcome, J Neurosurg, 129, 1550, 10.3171/2017.8.JNS163222
Huang, 2012, Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury, Cell Transplant, 21, S23, 10.3727/096368912X633734
Tabakow, 2014, Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging, Cell Transplant, 23, 1631, 10.3727/096368914X685131
Huang, 2009, Olfactory ensheathing cells transplantation for central nervous system diseases in 1, 255 patients (in Chinese), Chin J Reparative Reconstr Surg, 23, 14
Huang, 2020, Clinical neurorestorative cell therapies: Developmental process, current state and future prospective, J Neurorestoratol, 8, 61, 10.26599/JNR.2020.9040009
Vaquero, 2019, Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia, Cytotherapy, 21, 428, 10.1016/j.jcyt.2019.02.009
Huang, 2019, 2018 yearbook of neurorestoratology, J Neurorestoratol, 7, 11, 10.26599/JNR.2019.9040003
Huang, 2020, The 2019 yearbook of Neurorestoratology, J Neurorestoratol, 8, 1, 10.26599/JNR.2020.9040004
Huang, 2021, The 2020 Yearbook of Neurorestoratology, J Neurorestoratol, 9, 1, 10.26599/JNR.2021.9040002